Max Levitt, MD
Urology · Fairbanks, AKNPI 1487499307
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,223 of the $3,611 with a category attached, or 61.6%. 12 manufacturers reported payments, led by Teleflex LLC at 57.0% of the total.
Across 53 payments — averaging $68.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$2K
- Boston Scientific$527
- Calyxo, Inc.$347
- Olympus America Inc.$165
- Sumitomo Pharma America, Inc.$144
- Procept Biorobotics Corporation$111
- plus $260 from 6 others
What the payments were for
- Travel & lodging$1,38838%
- Food & beverage$2,22362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 14 | $2,057 |
| Boston Scientific | 14 | $527 |
| Calyxo, Inc. | 5 | $347 |
| Olympus America Inc. | 3 | $165 |
| Sumitomo Pharma America, Inc. | 3 | $144 |
| Procept Biorobotics Corporation | 2 | $111 |
| Endo USA, Inc. | 5 | $106 |
| 180 Medical, Inc. | 2 | $49 |
| Antares Pharma, Inc. | 2 | $40 |
| Urogen Pharma, Inc. | 1 | $26 |
| Novartis | 1 | $22 |
| Johnson & Johnson | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$1,712
- CVAC Aspiration System$200
- LithoVue$109
- GEMTESA$105
How this compares
$3,611 in reported general payments places this provider in the 65th percentile of 28 urology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 23 | $319 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $144 |
| Phenazopyridine Hcl | 12 | $142 |
| Levofloxacin | 27 | $72 |
| Naproxen | 16 | $54 |
Paid to pharmacies, not to this prescriber.
Other urology in Fairbanks
- David SharpFairbanks$6K
- Tony NimehFairbanks$4K
- Shannon SmithFairbanks$3K
- Joshua LoganAnchorage$16K
- William ClarkAnchorage$9K
- Elysia SpencerAnchorage$8K
- Andre GodetAnchorage$5K
- Bryan WilsonAnchorage$4K
- Doug ChoJber$4K
- Mariam MillerAnchorage$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.